ReviewDiscover oncology2025
Marjolin ulcer: a rare clinical entity that every health professional should be informed about: a narrative review.
Review in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Trapezius flap for reconstruction of malignant transformation of a chronic occipital burn scar with skull involvement in a 70-year-old man: a case report.International journal of surgery case reports · 2026Article
- Squamous cell carcinoma in neglected lumbar myelomeningocele successfully managed by multidisciplinary surgical reconstruction.Discover oncology · 2026Article
- Neoplastic Foot Ulcers: A Multicentre Retrospective Study.International wound journal · 2026Article
- Squamous Cell Carcinoma Arising from Chronic Osteomyelitis: A Single-Center Case Series of Six Patients.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Marjolin ulcer is a term used to refer to malignant degeneration of aggressive nature associated with chronic burn scars or chronic wounds most of the time. Marjolin ulcers are more common in men and are usually diagnosed in the 5th decade of life. It usually has a relatively poor prognosis because it is diagnosed late, and the mortality rate is around 20% on the average. It is important for all healthcare professionals who provide wound care to be knowledgeable about this issue. The patients with chronic wounds and long standing scars should be followed-up closely in this regard. Early and effective treatment of burns and chronic wounds is mandatory to prevent this condition. Appropriate follow-up and early biopsy at the time of detection of any suspicious change improve the prognosis and survival of patients as this approach will provide early diagnosis of Marjolin ulcers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.